RYR2 and Alzheimer disease: Short-term treatment with the RyR inhibitor dantrolene stabilizes Ca2+ signals, ameliorates cognitive decline and reduces neuropathology, amyloid load and memory impairments in various AD mouse models (Chakroborty et al., 2012; Oulès et al., 2012; Peng et al., 2012).